Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Accumulated Expenses (2016 - 2026)

Ekso Bionics Holdings has reported Accumulated Expenses over the past 14 years, most recently at $1.8 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses fell 24.36% to $1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 million, a 24.36% decrease, with the full-year FY2025 number at $1.8 million, down 24.36% from a year prior.
  • Accumulated Expenses reached $1.8 million in Q4 2025 per EKSO's latest filing, up from $531000.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $2.7 million in Q4 2023, with the low at $359000.0 in Q3 2023.
  • The 5-year median for Accumulated Expenses is $1.7 million (2021), against an average of $1.6 million.
  • Peak YoY movement for Accumulated Expenses: crashed 83.47% in 2023, then soared 450.14% in 2024.
  • Tracing EKSO's Accumulated Expenses over 5 years: stood at $2.3 million in 2021, then dropped by 19.83% to $1.8 million in 2022, then skyrocketed by 44.55% to $2.7 million in 2023, then fell by 11.71% to $2.4 million in 2024, then decreased by 24.36% to $1.8 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $1.8 million, $531000.0, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.